Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

PURPOSE: Preclinical models suggest that the use of anti–vascular endothelial growth factor (anti-VEGF) therapy with antiestrogens may prevent or delay the development of endocrine therapy resistance. We therefore performed a feasibility study to evaluate the safety of letrozole plus bevacizumab in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Traina, Tiffany A., Rugo, Hope S., Caravelli, James F., Patil, Sujata, Yeh, Benjamin, Melisko, Michele E., Park, John W., Geneus, Stephanie, Paulson, Matthew, Grothusen, Jill, Seidman, Andrew D., Fornier, Monica, Lake, Diana, Dang, Chau, Robson, Mark, Theodoulou, Maria, Flombaum, Carlos D., Norton, Larry, Hudis, Clifford A., Dickler, Maura N.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2010
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3940895/
https://ncbi.nlm.nih.gov/pubmed/19841327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8784
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars